IMPORTANCE Reported cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection likely underestimate the prevalence of infection in affected communities. Large-scale seroprevalence studies provide better estimates of the proportion of the population previously infected. OBJECTIVE To estimate prevalence of SARS-CoV-2 antibodies in convenience samples from several geographic sites in the US. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study performed serologic testing on a convenience sample of residual sera obtained from persons of all ages. The serum was collected from March 23 through May 12, 2020, for routine clinical testing by 2 commercial laboratory companies. Sites of collection were San Francisco Bay area,

No abstract

BACKGROUND Ebola virus has been detected in the semen of men after their recovery from Ebola virus disease (EVD). We report the presence of Ebola virus RNA in semen in a cohort of survivors of EVD in Sierra Leone. METHODS We enrolled a convenience sample of 220 adult male survivors of EVD in Sierra Leone, at various times after discharge from an Ebola treatment unit (ETU), in two phases (100 participants were in phase 1, and 120 in phase 2). Semen specimens obtained at baseline were tested by means of a quantitative reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay with the use of the target sequences of NP and VP40 (in phase 1) or NP and GP (in phase 2). This study did not evaluate directly the risk of sexual transmission of EVD. RESULTS Of 210 participants who provided an initial semen specimen for analysis, 57 (27%) had positive results on quantitative RT-PCR. Ebola virus RNA was detected in the semen of all 7 men with a specimen obtained within 3 months after ETU discharge, in 26 of 42 (62%) with a specimen obtained at 4 to 6 months, in 15 of 60 (25%) with a specimen obtained at 7 to 9 months, in 4 of 26 (15%) with a specimen obtained at 10 to 12 months, in 4 of 38 (11%) with a specimen obtained at 13 to 15 months, in 1 of 25 (4%) with a specimen obtained at 16 to 18 months, and in no men with a specimen obtained at 19 months or later. Among the 46 participants with a positive result in phase 1, the median baseline cycle-threshold values (higher values indicate lower RNA values) for the NP and VP40 targets were lower within 3 months after ETU discharge (32.4 and 31.3, respectively; in 7 men) than at 4 to 6 months (34.3 and 33.1; in 25), at 7 to 9 months (37.4 and 36.6; in 13), and at 10 to 12 months (37.7 and 36.9; in 1). In phase 2, a total of 11 participants had positive results for NP and GP targets (samples obtained at 4.1 to 15.7 months after ETU discharge); cycle-threshold values ranged from 32.7 to 38.0 for NP and from 31.1 to 37.7 for GP. CONCLUSIONS These data showed the long-term presence of Ebola virus RNA in semen and declining persistence with increasing time after ETU discharge. (Funded by the World Health Organization and others.)

Campylobacter jejuni, a gram-negative motile bacterium, secretes a set of proteins termed the Campylobacter invasion antigens (Cia proteins). The purpose of this study was to determine whether the flagellar apparatus serves as the export apparatus for the Cia proteins. Mutations were generated in five genes encoding three structural components of the flagella, the flagellar basal body (flgB and flgC), hook (flgE2), and filament (flaA and flaB) genes, as well as in genes whose products are essential for flagellar protein export (flhB and fliI). While mutations that affected filament assembly were found to be nonmotile (Mot ؊ ) and did not secrete Cia proteins (S ؊ ), a flaA (flaB ؉ ) filament mutant was found to be nonmotile but Cia protein secretion competent (Mot ؊ , S ؉ ). Complementation of a flaA flaB double mutant with a shuttle plasmid harboring either the flaA or flaB gene restored Cia protein secretion, suggesting that Cia export requires at least one of the two filament proteins. Infection of INT 407 human intestinal cells with the C. jejuni mutants revealed that maximal invasion of the epithelial cells required motile bacteria that are secretion competent. Collectively, these data suggest that the C. jejuni Cia proteins are secreted from the flagellar export apparatus.Campylobacter jejuni, a gram-negative motile bacterium, is a frequent cause of human gastrointestinal infections (39). The spectrum of disease observed in C. jejuni-infected individuals ranges from asymptomatic to severe enteritis characterized by fever, severe abdominal cramping, and diarrhea with blood and mucus (2, 4). By analogy with other more extensively characterized bacterial pathogens, the mechanism of C. jejunimediated enteritis is proposed to be multifactorial. Previous work has indicated that motility as well as the presence of the flagellum contributes to the ability of C. jejuni to colonize the intestinal tract of animals (33,36,42).The flagellum of C. jejuni is composed of a basal body, hook, and filament. The flagellar filament is comprised of two proteins, FlaA and FlaB, although it appears that FlaA is the preferred subunit (3). While the C. jejuni FlaA and FlaB flagellin proteins are transcribed concomitantly (16), the flaA gene is regulated by 28 and the flaB gene is regulated by 54 (3, 16). Hendrixson et al. (16) noted that a C. jejuni isolate deficient in 28 , which is encoded by the fliA gene, is able to assemble a truncated filament composed exclusively of the flagellin protein FlaB. This result indicates that the regulation of flagellar gene expression within C. jejuni differs from the regulation in more intensely studied systems such as that of Salmonella enterica. Unlike flagellar gene expression in C. jejuni, flagellar gene expression in S. enterica is initiated by a master regulator, while late gene expression and motility require 28 (1). Previous work in our laboratory has demonstrated that C. jejuni synthesizes a set of proteins during coculture with epithelial cells, a subset of which are secreted. The sec...

No abstract